Petros Pharma Stock (NASDAQ: PTPI) stock price, news, charts, stock research, profile.
Open | $0.640 |
Close | $0.640 |
Volume / Avg. | 77.235K / 958.728K |
Day Range | 0.635 - 0.660 |
52 Wk Range | 0.602 - 6.350 |
Market Cap | $4.366M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 24 |
Short Interest | 2.65% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Petros Pharma (NASDAQ: PTPI) through any online brokerage.
Other companies in Petros Pharma’s space includes: Cingulate (NASDAQ:CING), 60 Degrees (NASDAQ:SXTP), Akanda (NASDAQ:AKAN), Palisade Bio (NASDAQ:PALI) and Sonoma Pharmaceuticals (NASDAQ:SNOA).
The latest price target for Petros Pharma (NASDAQ: PTPI) was reported by Maxim Group on Friday, December 8, 2023. The analyst firm set a price target for 4.00 expecting PTPI to rise to within 12 months (a possible 529.92% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Petros Pharma (NASDAQ: PTPI) is $0.635 last updated April 26, 2024 at 4:38 PM EDT.
There are no upcoming dividends for Petros Pharma.
Petros Pharma’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Petros Pharma.
Petros Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.